ArticleAnnals of medicine and surgery (2012)2025
Heat shock protein and Alzheimer's disease: an updated systematic review.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Endogenous Expression of HSP70 and Thioredoxin-1 During Methamphetamine-Induced Degeneration.Biomedicines · 2026Article
- Taking its TOLL: the role of toll-like receptor 4 in human health and disease, and its potential as a therapeutic target.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alzheimer's disease (AD) is widely acknowledged as a global medical and social concern, and is characterized by the absence of a definitive cure. One of the primary challenges in AD research is the difficulty in targeting and isolating the intricate biochemical pathways that are implicated in the disease, particularly the mechanisms underlying protein misfolding that lead to the generation of harmful substances. Given the role of misfolding processes in the etiology of AD, there is potential for therapeutic interventions that focus on molecular chaperones. Objective: This review evaluated the association between AD and molecular chaperones, focusing specifically on the prominent heat shock proteins (HSPs) that serve as key constituents of the human chaperone. Methods: Publications from several electronic databases including PubMed, Scopus, and Web of Sciences, were examined by the reviewers, and 10 articles were selected after the screening process following the PRISMA guidelines. The search was conducted using specific keywords such as HSP, AD, neurocognitive disorders, and dementia. Results: The findings of our review indicate that HSPs play a role in the process of refolding or degrading misfolded proteins. Additionally, they contribute to the reduction of abnormal protein accumulation and neuronal degeneration, the mitigation of synaptic dysfunction, and the gradual and continuous decline of cognitive function observed in individuals with AD. Conclusion: The findings of this study indicate that HSPs have a role in the process of refolding or degrading misfolded proteins.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.